Publication: 4151

Publication: 4151

Protocol-defined biomarker analysis in the PALLAS (AFT-05) adjuvant trial: genomic subtype derived from RNA sequencing of HR+/HER2- early breast cancer.

Google Scholar

Citation:

Meeting Instance:: SABCS 2023
Year:: 2023
Type:: Abstract
Sub type:: Oral
Funding:: AFT
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:: Correl Sci NOS

Pharmas:: Pfizer
Grants:

Corr. Author:
Authors:: Daniel Stover Dominik Hlauschek Erica L Mayer W Fraser Symmans Mark Watson Iros Barozzi Martin Filipits Karla Ballman Merritxell Bellet-Ezquerra Justin Balko Gabor Rubovszky Nick Zdenkowski Adam Brufsky Guenther Steger Claudine Isaacs Sibylle Loibl Fernando Henao Carrasco Carsten Denkert Meredith Regan Yuan Liu Christian Fesl Patrick O'Brien Angela DeMichele Michael Gnant Otto Metzger

Networks:: CAPITAL, LAPS-MA036, LAPS-MO011, LAPS-OH007, LAPS-PA015, LAPS-TX035, OH070

Study: AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: